Anti PD-1 antibodies
US10428146B2 · kind B2 · utility
8Cited by
61References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 2015 |
| Grant date | Oct 1, 2019 |
| Priority date | — |
| Expiry date | Sep 10, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to antibodies and antigen-binding fragments thereof that bind to PD-1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-1 antibodies and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.